13F-HR filed by Yu Fan
Yu Fan filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 4 holding rows worth $8,464,000.
- Accession
- 0000950123-21-011094
- Filer
- CIK 1668029
- Filed
- 2021-08-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A combination report, 4 entries on the cover page, a total value of $8,464,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $8,464,000 with VALUE read as thousands by filing date, 13F file number 028-20833. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
Other managers
- reports for this filerABG Innovation Capital Partners III GP Limited 028-20837
- reports for this filerAlly Bridge Group (NY) LLC 028-20834
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ABG ACQUISITION CORP I | G00496102 | CL A SHS | 462,000 | $4,528,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 143,867 | $3,090,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 112,044 | $780,000 | thousands by filing date | |
| DIFFUSION PHARMACEUTICALS IN | 253748305 | COM PAR | 89,848 | $66,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-21-011094 | this filing | 2021-08-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000950123-21-012428 | base | 2021-09-17 | acceptance time not in the bulk data set |